TRAWS PHARMA(TRAW)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TRAW TRAWS PHARMA

已收盘 02-13 16:00:00 EST

1.92

+0.00

0.00%

盘后1.92

+0.000.00%

16:04 EST

最高2.07	最低1.86	成交量7.34万
今开1.91	昨收1.92	日振幅10.93%
总市值1,534万	流通市值1,138万	总股本799.09万
成交额14.71万	换手率1.24%	流通股本592.57万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TRAW","market":"US","secType":"STK","nameCN":"TRAWS PHARMA","latestPrice":1.92,"timestamp":1771016400000,"preClose":1.92,"halted":0,"volume":73423,"hourTrading":{"tag":"盘后","latestPrice":1.92,"preClose":1.92,"latestTime":"16:04 EST","volume":1,"amount":1.92,"timestamp":1771016688161,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0,"floatShares":5925700,"shares":7990867,"eps":-1.82,"marketStatus":"已收盘","change":0,"latestTime":"02-13 16:00:00 EST","open":1.91,"high":2.07,"low":1.8601,"amount":147123.862001,"amplitude":0.109323,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.82,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1771318800000},"marketStatusCode":5,"adr":0,"listingDate":1374724800000,"exchange":"NASDAQ","adjPreClose":1.92,"preHourTrading":{"tag":"盘前","latestPrice":1.94,"preClose":1.92,"latestTime":"08:15 EST","volume":101,"amount":195.880006,"timestamp":1770988519644,"change":0.02,"changeRate":0.010417,"amplitude":0.03125},"postHourTrading":{"tag":"盘后","latestPrice":1.92,"preClose":1.92,"latestTime":"16:04 EST","volume":1,"amount":1.92,"timestamp":1771016688161,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.501227,"impliedVol":1.6331,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/TRAW","defaultTab":"news","newsList":[{"id":"2610851910","title":"Traws Pharma, Inc.盘中异动 早盘股价大跌5.69%报1.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610851910","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610851910?lang=zh_cn&edition=full","pubTime":"2026-02-11 23:50","pubTimestamp":1770825012,"startTime":"0","endTime":"0","summary":"北京时间2026年02月11日23时50分，Traws Pharma, Inc.股票出现波动，股价快速下跌5.69%。截至发稿，该股报1.82美元/股，成交量1.9131万股，换手率0.24%，振幅5.66%。Traws Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.77%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家临床阶段的生物制药公司，致力于开发新型疗法，以针对呼吸道病毒性疾病对人类健康的关键威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211235012a6ef9df6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211235012a6ef9df6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"1112787706","title":"Traws药业完成Ratutrelvir在适用与不适用Paxlovid®的新冠患者中的临床研究入组；宣布计划为Tivoxavir Marboxil新增季节性流感预防性治疗适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=1112787706","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112787706?lang=zh_cn&edition=full","pubTime":"2026-01-26 21:32","pubTimestamp":1769434340,"startTime":"0","endTime":"0","summary":"Traws药业已顺利完成其候选药物Ratutrelvir针对适用及不适用Paxlovid®的新冠病毒感染者的临床试验患者招募工作。\n与此同时，该公司宣布将拓展其另一款药物Tivoxavir Marboxil的适应症范围，计划将其开发为季节性流感的预防性治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2603603079","title":"Traws Pharma, Inc.盘中异动 急速下挫5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603603079","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603603079?lang=zh_cn&edition=full","pubTime":"2026-01-15 01:14","pubTimestamp":1768410894,"startTime":"0","endTime":"0","summary":"北京时间2026年01月15日01时14分，Traws Pharma, Inc.股票出现波动，股价快速下挫5.59%。Traws Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家临床阶段的生物制药公司，致力于开发新型疗法，以针对呼吸道病毒性疾病对人类健康的关键威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115011454953ccbb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115011454953ccbb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"1105664831","title":"Traws Pharma Inc：Ratutrelvir展现出与Paxlovid™的显著不同的特征，副作用更少且未出现病毒反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=1105664831","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105664831?lang=zh_cn&edition=full","pubTime":"2025-12-17 19:12","pubTimestamp":1765969962,"startTime":"0","endTime":"0","summary":"Traws Pharma Inc：Ratutrelvir展现出与Paxlovid™的显著不同的特征，副作用更少且未出现病毒反弹","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"1177639705","title":"TRAWS PHARMA公布Ratutrelvir与Paxlovid™对比的积极中期临床数据，显示对不适合使用Paxlovid患者的疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=1177639705","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177639705?lang=zh_cn&edition=full","pubTime":"2025-12-17 19:12","pubTimestamp":1765969951,"startTime":"0","endTime":"0","summary":"TRAWS PHARMA公布Ratutrelvir与Paxlovid™的对比数据，展示其在不适合使用Paxlovid的COVID-19患者中具有积极的疗效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2586287406","title":"Traws Pharma, Inc.盘中异动 早盘急速拉升6.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586287406","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586287406?lang=zh_cn&edition=full","pubTime":"2025-11-25 23:17","pubTimestamp":1764083863,"startTime":"0","endTime":"0","summary":"北京时间2025年11月25日23时17分，Traws Pharma, Inc.股票出现波动，股价大幅拉升6.17%。Traws Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家临床阶段的生物制药公司，致力于开发新型疗法，以针对呼吸道病毒性疾病对人类健康的关键威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125231743a710ed57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125231743a710ed57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2582361182","title":"Traws Pharma, Inc.盘中异动 快速拉升12.25%报2.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582361182","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582361182?lang=zh_cn&edition=full","pubTime":"2025-11-10 22:39","pubTimestamp":1762785575,"startTime":"0","endTime":"0","summary":"北京时间2025年11月10日22时39分，Traws Pharma, Inc.股票出现异动，股价快速拉升12.25%。Traws Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。其相关个股中，Cogent Biosciences, Inc.、Inflarx N.V.、Pluri Inc.涨幅较大，Inflarx N.V.、Propanc Biopharma, Inc.、Innate Pharma较为活跃，换手率分别为78.46%、15.30%、8.72%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Cogent Biosciences, Inc.、Pluri Inc.，振幅分别为22.10%、20.18%、20.06%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家临床阶段的生物制药公司，致力于开发新型疗法，以针对呼吸道病毒性疾病对人类健康的关键威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111022393594fb9650&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111022393594fb9650&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"1157882863","title":"Chemdiv扩展与TRAWS PHARMA的Ratutrelvir的CMC服务合作，后者是一个在进行二期临床试验的潜在最佳Covid-19治疗药物","url":"https://stock-news.laohu8.com/highlight/detail?id=1157882863","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157882863?lang=zh_cn&edition=full","pubTime":"2025-10-31 00:00","pubTimestamp":1761840050,"startTime":"0","endTime":"0","summary":"Chemdiv扩展与TRAWS PHARMA的Ratutrelvir的CMC服务合作，后者是一个在进行二期临床试验的潜在最佳Covid-19治疗药物","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"1184440960","title":"TRAWS PHARMA启动Ratutrelvir二期新冠研究，首位患者已接受给药，预计2025年底公布结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1184440960","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184440960?lang=zh_cn&edition=full","pubTime":"2025-10-14 19:00","pubTimestamp":1760439648,"startTime":"0","endTime":"0","summary":"TRAWS PHARMA启动Ratutrelvir二期新冠研究，首位患者已接受给药，预计2025年底公布结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"1119026861","title":"TRAWS PHARMA任命John Leaman医学博士为独立董事，并正式确认两名核心高管职务","url":"https://stock-news.laohu8.com/highlight/detail?id=1119026861","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119026861?lang=zh_cn&edition=full","pubTime":"2025-10-06 19:02","pubTimestamp":1759748565,"startTime":"0","endTime":"0","summary":"TRAWS PHARMA任命John Leaman医学博士为独立董事，并正式确认两名核心高管职务","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2518475278","title":"Traws Pharma, Inc.盘中异动 股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518475278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518475278?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:22","pubTimestamp":1741616551,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时22分，Traws Pharma, Inc.股票出现波动，股价快速跳水5.30%。Traws Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为3401.51%、720.06%、414.27%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Biodexa Pharmaceuticals Plc，振幅分别为41.36%、40.24%、39.34%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家生物制药公司，专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022223196404282&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022223196404282&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2517161983","title":"Traws Pharma, Inc.盘中异动 快速拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517161983","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517161983?lang=zh_cn&edition=full","pubTime":"2025-03-06 23:13","pubTimestamp":1741274023,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日23时13分，Traws Pharma, Inc.股票出现异动，股价急速上涨5.05%。Traws Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。其相关个股中，Aeon Biopharma, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Plus Therapeutics, Inc.涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Aditxt, Inc.较为活跃，换手率分别为1510.12%、905.97%、76.46%，振幅较大的相关个股有Aeon Biopharma, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Moolec Science Sa C/Wts ，振幅分别为56.82%、44.64%、44.44%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家生物制药公司，专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306231343963c5603&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306231343963c5603&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2517910578","title":"Traws Pharma, Inc.盘中异动 早盘股价大涨6.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517910578","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517910578?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:30","pubTimestamp":1741185027,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时30分，Traws Pharma, Inc.股票出现波动，股价急速拉升6.69%。Traws Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Chimerix, Inc.、Silexion Therapeutics Corp涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Zyversa Therapeutics, Inc.较为活跃，换手率分别为310.54%、251.30%、183.65%，振幅较大的相关个股有4D Molecular Therapeutics, Inc.、Plus Therapeutics, Inc.、Zura Bio Limited，振幅分别为8.56%、6.59%、5.61%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家生物制药公司，专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223027963adbe6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223027963adbe6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2516632682","title":"Traws Pharma, Inc.盘中异动 股价大跌6.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516632682","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516632682?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:34","pubTimestamp":1741012446,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时34分，Traws Pharma, Inc.股票出现异动，股价大幅下跌6.95%。Traws Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Alto Neuroscience, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为47.66%、28.93%、27.72%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Spruce Biosciences, Inc.，振幅分别为33.98%、21.22%、19.25%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家生物制药公司，专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223406989a1018&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223406989a1018&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2514515373","title":"Traws Pharma, Inc.盘中异动 早盘大幅下挫5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514515373","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514515373?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:05","pubTimestamp":1740755127,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时05分，Traws Pharma, Inc.股票出现波动，股价快速跳水5.17%。Traws Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，Bioxcel Therapeutics, Inc.、Immunitybio, Inc.、Puma Biotechnology Inc涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为1009.23%、385.75%、319.45%，振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Bioxcel Therapeutics, Inc.，振幅分别为46.60%、42.89%、38.73%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家生物制药公司，专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228230527a25809d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228230527a25809d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2514851333","title":"Traws Pharma, Inc.盘中异动 大幅拉升10.00%报3.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514851333","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514851333?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:07","pubTimestamp":1740582421,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时07分，Traws Pharma, Inc.股票出现异动，股价快速上涨10.00%。截至发稿，该股报3.85美元/股，成交量1503股，换手率0.04%，振幅10.00%。Traws Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家生物制药公司，专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226230701abddf581&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226230701abddf581&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2514090251","title":"Traws Pharma, Inc.盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514090251","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514090251?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:38","pubTimestamp":1740494311,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时38分，Traws Pharma, Inc.股票出现异动，股价急速拉升5.00%。Traws Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Organovo Holdings, Inc.、Silexion Therapeutics Corp、Gt Biopharma, Inc.涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为813.36%、582.22%、503.58%，振幅较大的相关个股有Organovo Holdings, Inc.、Gt Biopharma, Inc.、Moleculin Biotech, Inc.，振幅分别为100.27%、33.50%、20.56%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家生物制药公司，专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223831a25388f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223831a25388f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2513272799","title":"Traws Pharma, Inc.盘中异动 早盘快速下挫5.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513272799","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513272799?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:48","pubTimestamp":1740408530,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时48分，Traws Pharma, Inc.股票出现波动，股价快速下跌5.79%。Traws Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为121.78%、52.90%、24.85%，振幅较大的相关个股有Pepgen Inc.、Vaxart, Inc. - Common Stock、Immunic, Inc.，振幅分别为137.23%、21.42%、20.47%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家生物制药公司，专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224224850abdb1244&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224224850abdb1244&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2513997212","title":"Traws Pharma, Inc.盘中异动 早盘股价大跌5.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513997212","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513997212?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:38","pubTimestamp":1740148682,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时38分，Traws Pharma, Inc.股票出现波动，股价大幅跳水5.76%。Traws Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Nkgen Biotech, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、蓝鸟生物较为活跃，换手率分别为73.56%、67.90%、21.07%，振幅较大的相关个股有Lexaria Bioscience Corp C/Wts 14/01/2026 、Osr Holdings Inc C/Wts 09/02/2028 、Osr Holdings, Inc.，振幅分别为33.83%、30.00%、25.39%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家生物制药公司，专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223802abd7b11c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223802abd7b11c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2512339144","title":"Traws Pharma, Inc.盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512339144","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512339144?lang=zh_cn&edition=full","pubTime":"2025-02-20 02:39","pubTimestamp":1739990349,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日02时39分，Traws Pharma, Inc.股票出现异动，股价快速下跌5.13%。Traws Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 02/09/2028 、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为665.03%、253.55%、224.59%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为267.43%、159.49%、61.99%。Traws Pharma, Inc.公司简介：Traws Pharma Inc 是一家生物制药公司，专注于开发流感、COVID和其他呼吸道感染的抗病毒药物和narazaciclib。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220023909abd52aad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220023909abd52aad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.onconova.com","stockEarnings":[{"period":"1week","weight":0.1163},{"period":"1month","weight":0.1925},{"period":"3month","weight":-0.1152},{"period":"6month","weight":0.2715},{"period":"1year","weight":-0.7213},{"period":"ytd","weight":0.6991}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":-0.018},{"period":"3month","weight":0.0139},{"period":"6month","weight":0.0588},{"period":"1year","weight":0.1291},{"period":"ytd","weight":-0.001}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Traws Pharma, Inc.于1998年12月22日在特拉华州注册成立，于1999年1月1日开始运营，是一家临床阶段的生物制药公司，专注于发现和开发治疗癌症的新型小分子候选药物。Traws正在开发用于流感、COVID和其他呼吸道感染的下一代、同类最佳的抗病毒药物，以及用于肿瘤学的narazaciclib。","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.179894},{"month":2,"riseRate":0.384615,"avgChangeRate":-0.077437},{"month":3,"riseRate":0.416667,"avgChangeRate":-0.052994},{"month":4,"riseRate":0.25,"avgChangeRate":-0.132766},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.059914},{"month":6,"riseRate":0.75,"avgChangeRate":0.06745},{"month":7,"riseRate":0.25,"avgChangeRate":-0.019463},{"month":8,"riseRate":0.230769,"avgChangeRate":-0.120142},{"month":9,"riseRate":0.384615,"avgChangeRate":-0.103896},{"month":10,"riseRate":0.230769,"avgChangeRate":-0.080722},{"month":11,"riseRate":0.461538,"avgChangeRate":-0.058331},{"month":12,"riseRate":0.307692,"avgChangeRate":0.009577}],"exchange":"NASDAQ","name":"TRAWS PHARMA","nameEN":"TRAWS PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TRAWS PHARMA(TRAW)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供TRAWS PHARMA(TRAW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"TRAWS PHARMA,TRAW,TRAWS PHARMA股票,TRAWS PHARMA股票老虎,TRAWS PHARMA股票老虎国际,TRAWS PHARMA行情,TRAWS PHARMA股票行情,TRAWS PHARMA股价,TRAWS PHARMA股市,TRAWS PHARMA股票价格,TRAWS PHARMA股票交易,TRAWS PHARMA股票购买,TRAWS PHARMA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TRAWS PHARMA(TRAW)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供TRAWS PHARMA(TRAW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}